Bridgefront Capital’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,773
Closed -$349K – 638
2026
Q1
$349K Buy
+6,773
New +$474K 0.09% 351
2025
Q4
– Sell
-5,010
Closed -$372K – 654
2025
Q3
$372K Buy
5,010
+2,901
+138% +$294K 0.11% 332
2025
Q2
$274K Buy
2,109
+756
+56% +$110K 0.07% 458
2025
Q1
$216K Buy
+1,353
New +$245K 0.06% 495
2023
Q4
– Sell
-2,950
Closed -$585K – 460
2023
Q3
$585K Buy
2,950
+894
+43% +$225K 0.41% 53
2023
Q2
$667K Buy
+2,056
New +$587K 0.36% 67

Other funds holding INSP

Bridgefront Capital's INSP Position: Q2 2026 in Review

Bridgefront Capital sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 6,773 shares — an estimated $349K sold.

Bridgefront Capital first reported a position in INSP in Q2 2023 and held it in 6 quarters. The position peaked at $667K in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Bridgefront Capital reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 6,773 Inspire Medical Systems shares in Q2 2026, an estimated $349K.
  • Bridgefront Capital first reported a position in Inspire Medical Systems in Q2 2023 and held it in 6 quarters.
  • Bridgefront Capital's Inspire Medical Systems position peaked at $667K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.